Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence X Yu

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The AAPS Journal|May 1, 2008
Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applicationsBarbara M Davit, Dale P Conner, Beth Fabian-Fritsch, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 25, 2005
Determination of plasma and brain levels of isotretinoin in mice following single oral dose by high-performance liquid chromatographyYongsheng Yang, Patrick J Faustino, P Scott Pine, et al.
Molecular Pharmaceutics|July 20, 2005
The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugsLawrence X Yu, Arthur B Straughn, Patrick J Faustino, et al.
International Journal of Pharmaceutics|January 30, 2008
Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blueYongsheng Yang, Patrick J Faustino, Joseph J Progar, et al.
Pharmaceutical Research|August 16, 2002
Biopharmaceutics classification system: the scientific basis for biowaiver extensionsLawrence X Yu, Gordon L Amidon, James E Polli, et al.
Molecular Pharmaceutics|October 28, 2017
Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug DevelopmentMehul U Mehta, Ramana S Uppoor, Dale P Conner, et al.
The AAPS Journal|September 14, 2012
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug AdministrationBarbara M Davit, Mei-Ling Chen, Dale P Conner, et al.
Pharmaceutics|May 25, 2024
Effect of Antioxidants in Medicinal Products on Intestinal Drug TransportersChetan P Kulkarni, Jia Yang, Megan L Koleske, et al.
Pharmaceutical Research|May 13, 2003
Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applicationsLawrence X Yu, M Scott Furness, Andre Raw, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2011
Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary reportMei-Ling Chen, Vinod P Shah, Daan J Crommelin, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The AAPS Journal|May 1, 2008
Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applicationsBarbara M Davit, Dale P Conner, Beth Fabian-Fritsch, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 25, 2005
Determination of plasma and brain levels of isotretinoin in mice following single oral dose by high-performance liquid chromatographyYongsheng Yang, Patrick J Faustino, P Scott Pine, et al.
Molecular Pharmaceutics|July 20, 2005
The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugsLawrence X Yu, Arthur B Straughn, Patrick J Faustino, et al.
International Journal of Pharmaceutics|January 30, 2008
Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blueYongsheng Yang, Patrick J Faustino, Joseph J Progar, et al.
Pharmaceutical Research|August 16, 2002
Biopharmaceutics classification system: the scientific basis for biowaiver extensionsLawrence X Yu, Gordon L Amidon, James E Polli, et al.
Molecular Pharmaceutics|October 28, 2017
Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug DevelopmentMehul U Mehta, Ramana S Uppoor, Dale P Conner, et al.
The AAPS Journal|September 14, 2012
Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug AdministrationBarbara M Davit, Mei-Ling Chen, Dale P Conner, et al.
Pharmaceutics|May 25, 2024
Effect of Antioxidants in Medicinal Products on Intestinal Drug TransportersChetan P Kulkarni, Jia Yang, Megan L Koleske, et al.
Pharmaceutical Research|May 13, 2003
Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applicationsLawrence X Yu, M Scott Furness, Andre Raw, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2011
Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary reportMei-Ling Chen, Vinod P Shah, Daan J Crommelin, et al.
Pageof 8